Exscientia PLC at Barclays Global Healthcare Conference Transcript
So thank you so much. Good afternoon, everybody, and welcome to Barclays Global Healthcare Conference in Miami. Do e-mail us or connect with us on Bloomberg if there are any questions you need to address. My name is Peter Lawson. I'm one of the SMID-cap biotech analysts at Barclays, covering predominantly oncology-related companies. Really happy to have up on stage with me from management from Exscientia. We've got Andrew Hopkins, CEO, Co-founder; and Ben Taylor, CFO. So thanks so much today for the time. Good to see you.
Questions & Answers
And then, I guess, AACR is around the quarter essentially. We have more interesting data kind of emerging, great to kind of walk through some of those molecules. I guess the LSD won the differentiation there and kind of how you design that molecule and how you think it could have a better LSD1. That'll be the first question.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
